Artiva Biotherapeutics Inc
(ARTV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Cash Flows From Operating Activities | ||
| Net Income | -65,373 | -28,720 |
| Depreciation Amortization | 2,431 | 2,266 |
| Accounts receivable | 1,034 | -510 |
| Accounts payable and accrued liabilities | 519 | -408 |
| Other Working Capital | -325 | -28,280 |
| Other Operating Activity | 6,682 | 8,222 |
| Operating Cash Flow | $-55,032 | $-47,430 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | -119,821 | -22,717 |
| PPE Investments | -642 | -3,258 |
| Investing Cash Flow | $-120,463 | $-25,975 |
| Cash Flows From Financing Activities | ||
| Debt Issued | N/A | 24,393 |
| Debt Repayment | -149 | N/A |
| Common Stock Issued | 166,558 | 10 |
| Common Stock Repurchased | N/A | -12 |
| Other Financing Activity | -4,183 | 0 |
| Financing Cash Flow | $162,226 | $24,391 |
| Beginning Cash Position | 53,762 | 102,776 |
| End Cash Position | 40,493 | 53,762 |
| Net Cash Flow | $-13,269 | $-49,014 |
| Free Cash Flow | ||
| Operating Cash Flow | -55,032 | -47,430 |
| Capital Expenditure | -642 | -3,258 |
| Free Cash Flow | -55,674 | -50,688 |